Ardelyx's Stock Declines Post-Earnings Amid Ibsrela Outlook Concerns

Ardelyx's stock declined after its earnings report, attributed to concerns regarding the outlook for its drug Ibsrela.

20 Feb, 17:24 — 20 Feb, 17:24